Suitability of skin integrity tests for dermal absorption studies in vitro

Toxicology in Vitro

Volumn 29, Issue 1, 2015, Pages 113-123

  Guth, Katharina ^a   Schäfer Korting, Monika ^b   Fabian, Eric ^a   Landsiedel, Robert ^a   van Ravenzwaay, Ben ^a  

^a BASF SE   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Dermal absorption; Integrity tests; Internal reference standard; Skin barrier function; TEER; TEWL

Indexed keywords

ALCOHOL; CAFFEINE; MANNITOL; METHYLENE BLUE; TESTOSTERONE; TRITIUM; WATER;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FULL THICKNESS SKIN GRAFT; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PHYSICAL CHEMISTRY; SKIN ABSORPTION; SKIN CONDUCTANCE; SKIN PERMEABILITY; SKIN WATER LOSS; SPLIT THICKNESS SKIN GRAFT; WATER TRANSPORT; ANIMAL; DIAGNOSTIC USE; DRUG EFFECTS; ELECTRODERMAL RESPONSE; METABOLISM; RAT; SKIN; THERMOREGULATION;

ANIMALS; FEMALE; GALVANIC SKIN RESPONSE; HUMANS; IN VITRO TECHNIQUES; METHYLENE BLUE; RATS; SKIN; SKIN ABSORPTION; WATER LOSS, INSENSIBLE;

EID: 84908374204     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2014.09.007     Document Type: Article

References (44)

1. Ackermann K., Borgia S.L., Korting H.C., Mewes K.R., Schäfer-Korting M. The Phenion (R) full-thickness skin model for percutaneous absorption testing. Skin Pharmacol. Physiol. 2010, 23:105-112.
2. Balaguer A., Salvador A., Chisvert A., Melia M., Herraez M., Diez O. A liquid chromatography-fluorimetric method for the in vitro estimation of the skin penetration of disodium phenyldibenzimidazole tetrasulfonate from sunscreen formulations through human skin. Anal. Bioanal. Chem. 2006, 385:1225-1232.
3. Barry, B.W., 1987. Penetration enhancers - mode of action in humans. In: Shroot, B., Schäfer, H. (Eds.), Skin Pharmacokinetics, pp. 121-137.
4. Brain, K.R., James, V.J., Walters, K.A., 1995. Validation of the integrity of epidermal membranes during assessment of percutaneous penetration. Predict. Percut. Penet.
5. Britisch Crop Protection Council, 2011. The e-pesticide manual V5.2. British Crop Production Council, Hampshire, UK.
6. Bronaugh R.L., Stewart R.F., Simon M. Methods for in vitro percutaneous-absorption studies. 7. Use of excised human-skin. J. Pharm. Sci. 1986, 75:1094-1097.
7. Buist H.E., van de Sandt J.J.M., van Burgsteden J.A., de Heer C. Effects of single and repeated exposure to biocidal active substances on the barrier function of the skin in vitro. Regul. Toxicol. Pharmacol. 2005, 43:76-84.
8. Chilcott R.P., Dalton C.H., Emmanuel A.J., Allen C.E., Bradley S.T. Transepidermal water loss does not correlate with skin barrier function in vitro. J. Invest. Dermatol. 2002, 118:871-875.
9. Davies D.J., Ward R.J., Heylings J.R. Multi-species assessment of electrical resistance as a skin integrity marker for in vitro percutaneous absorption studies. Toxicol. In Vitro 2004, 18:351-358.
10. Diembeck W., Beck H., Benech-Kieffer F., Courtellemont P., Dupuiss J., Lovell W., Paye M., Spengler J., Steiling W. Test guidelines for in vitro assessment of dermal absorption and percutaneous penetration of cosmetic ingredients. Food Chem. Toxicol. 1999, 37:191-205.
11. Dugard P.H., Scott R.C. A method of predicting percutaneous-absorption rates from vehicle to vehicle - an experimental assessment. Int. J. Pharm. 1986, 28:219-227.
12. EFSA Panel on Plant Protection Products and their Residues, 2012. Guidance on Dermal Absorption. EFSA J., 10.
13. Elkeeb R., Hui X.Y., Chan H.D., Tian L.L., Maibach H.I. Correlation of transepidermal water loss with skin barrier properties in vitro: comparison of three evaporimeters. Skin Res. Technol. 2010, 16:9-15.
14. Fasano W.J., Manning L.A., Green J.W. Rapid integrity assessment of rat and human epidermal membranes for in vitro dermal regulatory testing: correlation of electrical resistance with tritiated water permeability. Toxicol. In Vitro 2002, 16:731-740.
15. Flynn G.L., Yalkowsk S.H., Roseman T.J. Mass-transport phenomena and models - theoretical concepts. J. Pharm. Sci. 1974, 63:479-510.
16. Guth, K., 2013. Models for percutaneous absorption - influential parameters and in silico predictions. Freie Universität, Berlin.
17. Imhof R., De Jesus M., Xiao P., Ciortea L.I., Berg E. Closed-chamber transepidermal water loss measurement: microclimate, calibration and performance. Int. J. Cosmetic Sci. 2009, 31:97-118.
18. Kielhorn J., Melching-Kollmuss S., Mangelsdorf I. Dermal absorption, Environmental Health Criteria 235 2006, World Health Organization.
19. Kuechler S., Henkes D., Eckl K.M., Ackermann K., Plendl J., Korting H.C., Hennies H.C., Schäfer-Korting M. Hallmarks of atopic skin mimicked in vitro by means of a skin disease model based on FLG knock-down. Atla-Altern. Lab. Animals 2011, 39:471-480.
20. Lawrence J.N. Electrical resistance and tritiated water permeability as indicators of barrier integrity of in vitro human skin. Toxicol. In Vitro 1997, 11:241-249.
21. Leo A., Hansch C., Elkins D. Partition coefficients and their uses. Chem. Rev. 1971, 71. 525+.
22. Levin J., Maibach H. The correlation between transepidermal water loss and percutaneous absorption: an overview. J. Control. Rel. 2005, 103:291-299.
23. Marzulli F.N., Brown D.W.C.M.H.I. Techniques for studying skin penetration. Toxicol. Appl. Pharmacol. 1969, 3:76-83.
24. Meidan V.M., Roper C.S. Inter- and intra-individual variability in human skin barrier function: a large scale retrospective study. Toxicol. In Vitro 2008, 22:1062-1069.
25. Merck, 2006. Safety Data Sheet Caffeine.
26. Netzlaff F., Kostka K.H., Lehr C.M., Schäfer U.F. TEWL measurements as a routine method for evaluating the integrity of epidermis sheets in static Franz type diffusion cells in vitro. Limitations shown by transport data testing. Eur. J. Pharm. Biopharm. 2006, 63:44-50.
27. OECD, 2004a. Guidance document for the conduct of skin absorption studies - OECD Series in Testing and assessment - Number 28. Organisation for Economic Co-operation and Development.
28. OECD, 2004b. OECD Guideline for the testing of chemicals. Skin absorption: in vitro method 428. Organisation for Economic Co-operation and Development.
29. Oji V., Eckl K.M., Aufenvenne K., Natebus M., Tarinski T., Ackermann K., Seller N., Metze D., Nurnberg G., Folster-Holst R., Schafer-Korting M., Hausser I., Traupe H., Hennies H.C. Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin disease. Am. J. Human Genet. 2010, 87:274-281.
30. Peck K.D., Ghanem A.H., Higuchi W.I. The effect of temperature upon the permeation of polar and ionic solutes through human epidermal membrane. J. Pharm. Sci. 1995, 84:975-982.
31. Pendlington R.U., Sanders D.J., Cooper K.J., Howes D., Lovell W. The use of sucrose as a standard penetration in in vitro percutaneous penetration experiments. Perspectives in Percutaneous Penetration 1997, 55. Wiley-Blackwell, vol. 5a.
32. Riviere J.E. Absorption. Comparative Pharmacokinetics 2011, 39-71. Wiley-Blackwell. J.E. Riviere (Ed.).
33. Roberts M.S., Cross S.E. Skin transport. Dermatological and Transdermal Formulations 2002, 89-195. Marcel Dekker Inc, New York. K.A. Walters (Ed.).
34. Rougier A., Lotte C., Maibach H.I. Invivo relationship between trans-epidermal water-loss and percutaneous-absorption in man. Clin. Res. 1988, 36:A690.
35. Schäfer, H., Redelmeier, T.E., 1996a. Factors effecting percutaneous absorption. In: Schäfer, H., Redelmeier, T.E., Skin Barrier, Principles of Percutaneous Absorption, 153-212.
36. Schäfer, H., Redelmeier, T.E., 1996b Prediction and Measurement of Percutaneous Absorption. In: Schäfer, H., Redelmeier, T.E., Skin Barrier, Principles of Percutaneous Absorption, 118-152.
37. Schäfer-Korting M., Bock U., Gamer A., Haberland A., Haltner-Ukomadu E., Kaca M., Kamp H., Kietzmann M., Korting H.C., Krachter H.U., Lehr C.M., Liebsch M., Mehling A., Netzlaff F., Niedorf F., Rubbelke M.K., Schäfer U., Schmidt E., Schreiber S., Schroder K.R., Spielmann H., Vuia A. Reconstructed human epidermis for skin absorption testing: results of the German prevalidation study. Atla-Altern. Lab. Animals 2006, 34:283-294.
38. Schäfer-Korting M., Bock U., Diembeck W., Duesing H.J., Gamer A., Haltner-Ukomadu E., Hoffmann C., Kaca M., Kamp H., Kersen S., Kietzmann M., Korting H.C., Krachter H.U., Lehr C.M., Liebsch M., Mehling A., Mueller-Goymann C., Netzlaff F., Niedorf F., Rubbelke M.K., Schäfer U., Schmidt E., Schreiber S., Spielmann H., Vuia A., Weimer M. The use of reconstructed human epidermis for skin absorption testing: results of the validation study. Atla-Altern. Lab. Animals 2008, 36:161-187.
39. Shah D.K., Khandavilli S., Panchagnula R. Alteration of skin hydration and its barrier function by vehicle and permeation enhancers: a study using TGA, FTIR, TEWL and drug permeation as markers. Meth. Find. Exp. Clin. Pharmacol. 2008, 30:499-512.
40. Sigma-Aldrich, 2007. Sicherheitsdatenblatt D-Mannitol.
41. Southwell D., Barry B.W., Woodford R. Variations in permeability of human-skin within and between specimens. Int. J. Pharm. 1984, 18:299-309.
42. van de Sandt J.J.M., van Burgsteden J.A., Cage S., Carmichael P.L., Dick I., Kenyon S., Korinth G., Larese F., Limasset J.C., Maas W.J.M., Montomoli L., Nielsen J.B., Payan J.P., Robinson E., Sartorelli P., Schaller K.H., Wilkinson S.C., Williams F.M. In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study. Regul. Toxicol. Pharmacol. 2004, 39:271-281.
43. Walters K.A., Brain K.R., Howes D., James V.J., Kraus A.L., Teetsel N.M., Toulon M., Watkinson A.C., Gettings S.D. Percutaneous penetration of octyl salicylate from representative sunscreen formulations through human skin in vitro. Food Chem. Toxicol. 1997, 35:1219-1225.
44. Yalkowsky S.H., Valvani S.C., Roseman T.J. Solubility and partitioning. 6. Octanol solubility and octanol-water partition-coefficients. J. Pharm. Sci. 1983, 72:866-870.